- Home
- LIQT vs IBIO Comparison
LIQT vs IBIO Comparison
Compare LIQT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIQT
- IBIO
- Stock Information
- Founded
- LIQT 2004
- IBIO 2008
- Country
- LIQT Denmark
- IBIO United States
- Employees
- LIQT N/A
- IBIO N/A
- Industry
- LIQT Industrial Machinery/Components
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- LIQT Technology
- IBIO Health Care
- Exchange
- LIQT Nasdaq
- IBIO Nasdaq
- Market Cap
- LIQT 16.1M
- IBIO 15.9M
- IPO Year
- LIQT N/A
- IBIO N/A
- Fundamental
- Price
- LIQT $1.70
- IBIO $0.71
- Analyst Decision
- LIQT Strong Buy
- IBIO Strong Buy
- Analyst Count
- LIQT 2
- IBIO 3
- Target Price
- LIQT $4.80
- IBIO $4.87
- AVG Volume (30 Days)
- LIQT 15.9K
- IBIO 5.3M
- Earning Date
- LIQT 08-13-2025
- IBIO 05-02-2025
- Dividend Yield
- LIQT N/A
- IBIO N/A
- EPS Growth
- LIQT N/A
- IBIO N/A
- EPS
- LIQT N/A
- IBIO N/A
- Revenue
- LIQT $14,986,815.00
- IBIO $375,000.00
- Revenue This Year
- LIQT $36.89
- IBIO $36.00
- Revenue Next Year
- LIQT $16.33
- IBIO N/A
- P/E Ratio
- LIQT N/A
- IBIO N/A
- Revenue Growth
- LIQT N/A
- IBIO 650.00
- 52 Week Low
- LIQT $1.34
- IBIO $0.64
- 52 Week High
- LIQT $3.20
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- LIQT 52.96
- IBIO 37.70
- Support Level
- LIQT $1.58
- IBIO $0.68
- Resistance Level
- LIQT $1.64
- IBIO $1.04
- Average True Range (ATR)
- LIQT 0.09
- IBIO 0.12
- MACD
- LIQT -0.01
- IBIO -0.00
- Stochastic Oscillator
- LIQT 44.83
- IBIO 7.89
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.